Changeflow GovPing Pharma & Drug Safety EPO Patent Publication: Novel Composition for H...
Routine Notice Added Final

EPO Patent Publication: Novel Composition for Hair and Scalp Condition

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Pharma (A61K)
Published March 18th, 2026
Detected March 23rd, 2026
Email

Summary

The European Patent Office has published a new patent application, EP4511051A1, detailing a novel composition for improving hair and scalp condition. The publication includes details on the applicants, inventors, and International Patent Classifications related to the composition.

What changed

The European Patent Office (EPO) has published patent application EP4511051A1, titled "Novel Composition for Improvement of Hair and Scalp Condition." This publication, dated March 18, 2026, details a new formulation for hair and scalp care, listing Lucas Meyer Cosmetics as the applicant and Romain Duroux and Joan Attia as inventors. The application falls under various International Patent Classifications (IPC) including A61K (Preparations for medical, dental or toilet purposes) and A61P (Therapeutic activity of substances).

This is a patent publication, not a regulatory rule or guidance with direct compliance obligations for businesses. However, it signifies new intellectual property in the cosmetics and pharmaceutical sectors. Companies operating in these areas, particularly those developing or manufacturing hair and scalp care products, should be aware of this publication as it may impact their own product development, patent strategies, and competitive landscape within the designated states listed (including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR).

Source document (simplified)

← EPO Patent Bulletin

NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION

Publication EP4511051A1 Kind: A1 Mar 18, 2026

Applicants

Lucas Meyer Cosmetics

Inventors

DUROUX, Romain, ATTIA, Joan

IPC Classifications

A61K 36/61 20060101AFI20231027BHEP A61K 8/00 20060101ALI20231027BHEP A61K 9/00 20060101ALI20231027BHEP A61P 17/00 20060101ALI20231027BHEP A61P 29/00 20060101ALI20231027BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4511051A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development Intellectual Property Management
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Cosmetics Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.